Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 351.85
+2.45 (0.70%)
Oct 14, 2025, 3:30 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 469.52 billion as of October 14, 2025. Its market cap has increased by 5.62% in one year.
Market Cap
469.52B
Enterprise Value
668.17B
Revenue
157.71B
Ranking
n/a
PE Ratio
109.67
Stock Price
351.85
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 469.52B, an increase of 933.88%. That is a compound annual growth rate of 11.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 469.52B | 7.38% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | 551.59B | 58.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,009.05B |
| Divi's Laboratories | 1,718.78B |
| Cipla | 1,261.57B |
| Apollo Hospitals Enterprise | 1,104.41B |
| Mankind Pharma | 1,015.34B |
| Zydus Lifesciences | 999.64B |
| Fortis Healthcare | 800.48B |
| Aurobindo Pharma | 656.48B |